Indonesia vs Mozambique: Immunization, Hib3
Indonesia
69.0%
in 2024
Mozambique
70.0%
in 2024
Indonesia rank
169th
Mozambique rank
166th
Immunization, Hib3 over time
- Indonesia
- Mozambique
How they compare
Mozambique currently reports 70.0% against 69.0% in Indonesia, a difference of 1.0%.
The two have swapped places 2 times across 12 shared years of data; in 2013 it was Mozambique ahead.
Indonesia ranks 169th and Mozambique ranks 166th of 191 countries.
Across the 2 decades both report, Indonesia averaged higher in 1 and Mozambique in 1.
Head to head by decade
| Decade | Indonesia | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.0% | 84.6% | 20.6% | Mozambique |
| 2020s | 72.0% | 64.4% | 7.6% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Indonesia or Mozambique?
- Mozambique, at 70.0% against 69.0% in Indonesia as of 2024.
- What is the difference in immunization, hib3 between Indonesia and Mozambique?
- 1.0%, with Mozambique ahead.
- How many years of comparable data are there for Indonesia and Mozambique?
- 12 years are reported by both, from 2013 to 2024.
- How do Indonesia and Mozambique rank globally for immunization, hib3?
- Indonesia ranks 169th and Mozambique ranks 166th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.